Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Diabetes mellitus (Involvement kidney).php on line 2
Diabetes mellitus (Involvement kidney)
LE WE PMID CA
Diabetes mellitus (Involvement kidney)671Diabetes mellitus (Folgeerkrankungen Niere)

Autophagy

Bradykinin

C Peptide

Carbonyl stress

Cardiorenal syndrome

Db mouse

Diabetes mellitus (BASKET)

Diabetes mellitus (Involvement kidney)

Endothelial dysfunction

ERS UFR (Diseases)

Fatty acids (Free)

GADD153 CHOP

Glycemic index

IGF1

Kidney (Disease models)

Kidney (Fibrosis)

Kidney (Glomerular permselectivity)

Kidney (Glomerulus)

Kidney (Hyperfiltration)

Kidney (Podocytes)

Kidney (Progression of renal disease)

Klotho

Matrix metalloproteinase

MCP1 Monocyte chemotactic protein1

Microalbuminuria

Nephroprotective renoprotective agents

Palmitate

RAAS (Renin angiotensin system)

Telmisartan

TGF beta

TRAIL APO2

TRB3

TWEAK Fn14

VEGF

1978  
1
End-stage diabetic nephropathy.
[363228] Br Med J 2(6146): 1175-6 (1978)
2005  
2
Initiation, progression and remission of diabetic nephropathy.
[16764047] Dan Med Bull 52(4): 119-42 (2005)
2004  
3
Angiotensin II receptor blockade in diabetic nephropathy.
[16009059] Dan Med Bull 51(3): 274-94 (2004)
1999  
4
Nephropathy in type 2 diabetes.
[10081514] J Intern Med 245(2): 111-26 (1999)
2002  
5
Pathogenesis of renal microvascular complications in diabetes mellitus.
[12607589] Neth J Med 60(10): 390-6 (2002)
2001  
6
Management of diabetic nephropathy.
[11385086] J R Soc Med 94(5): 210-7 (2001)
2000  
7
Diabetic nephropathy. Prevention and early referral.
[10752002] Can Fam Physician 46(-): 636-42 (2000)
2009  
8
Angiotensin receptor blockers for the reduction of proteinuria in diabetic patients with overt nephropathy: results from the AMADEO study.
[19436679] Vasc Health Risk Manag 5(1): 129-40 (2009)
2005  
9
Systematic review on urine albumin testing for early detection of diabetic complications.
[16095545] Health Technol Assess 9(30): iii-vi, xiii-163 (2005)
2008  
10
Low-protein diet for diabetic nephropathy: a meta-analysis of randomized controlled trials.
[18779281] Am J Clin Nutr 88(3): 660-6 (2008)
2008  
11
Do low-protein diets retard the loss of kidney function in patients with diabetic nephropathy?
[18779271] Am J Clin Nutr 88(3): 593-4 (2008)
2004  
12
From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines.
[15583025] Endocr Rev 25(6): 971-1010 (2004)
2008  
13
MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy.
[18272603] Am J Physiol Renal Physiol 294(4): F697-701 (2008)
2008  
14
Diabetic nephropathy: nitric oxide and renal medullary hypoxia.
[18003855] Am J Physiol Renal Physiol 294(1): F28-9 (2008)
2008  
15
Reduced nitric oxide in diabetic kidneys due to increased hepatic arginine metabolism: implications for renomedullary oxygen availability.
[17942569] Am J Physiol Renal Physiol 294(1): F30-7 (2008)
2004  
16
Kidney function in early diabetes: the tubular hypothesis of glomerular filtration.
[14656757] Am J Physiol Renal Physiol 286(1): F8-15 (2004)
1978  
17
Diabetic glomerulosclerosis: current status.
[354765] Can Med Assoc J 119(2): 146-53 (1978)
2008  
18
From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy.
[18511444] Diabetes 57(6): 1439-45 (2008)
2005  
19
From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy.
[15919782] Diabetes 54(6): 1626-34 (2005)
2005  
20
2005  
21
Diabetic nephropathy: diagnosis, prevention, and treatment.
[15616252] Diabetes Care 28(1): 164-76 (2005)
2004  
22
Implementation of guidelines for the prevention of diabetic nephropathy.
[14988308] Diabetes Care 27(3): 803-4 (2004)
2004  
23
2003  
24
Identification and management of diabetic nephropathy in the diabetes clinic.
[12766114] Diabetes Care 26(6): 1806-11 (2003)
2003  
25
1998  
26
American Diabetes Association annual meeting, 1997, and the Teczem Consultant Meeting. Diabetic nephropathy.
[9540001] Diabetes Care 21(2): 315-9 (1998)
2000  
27
Potential influence of lipids in diabetic nephropathy: insights from experimental data and clinical studies.
[11011217] Diabetes Metab 26(4): 254-64 (2000)
2006  
28
Mechanisms of diabetic nephropathy: role of hypertension.
[16952978] Hypertension 48(4): 519-26 (2006)
1999  
29
Carbonyl stress in the pathogenesis of diabetic nephropathy.
[10361902] Intern Med 38(4): 309-14 (1999)
2007  
30
Nodular glomerulosclerosis in the nondiabetic smoker.
[17568019] J Am Soc Nephrol 18(7): 2032-6 (2007)
2006  
31
Enhancing the predictive value of urinary albumin for diabetic nephropathy.
[16394108] J Am Soc Nephrol 17(2): 339-52 (2006)
2005  
32
Antihypertensive agents for primary prevention of diabetic nephropathy.
[16135776] J Am Soc Nephrol 16(10): 3081-91 (2005)
2005  
33
Mouse models of diabetic nephropathy.
[15563560] J Am Soc Nephrol 16(1): 27-45 (2005)
2003  
34
Overview of glucose signaling in mesangial cells in diabetic nephropathy.
[12707407] J Am Soc Nephrol 14(5): 1374-82 (2003)
2003  
35
Extracellular matrix metabolism in diabetic nephropathy.
[12707406] J Am Soc Nephrol 14(5): 1358-73 (2003)
1998  
36
The nephropathy of non-insulin-dependent diabetes: predictors of outcome relative to diverse patterns of renal injury.
[9848788] J Am Soc Nephrol 9(12): 2336-43 (1998)
1998  
37
Nephropathy of type-2 diabetes mellitus.
[9808106] J Am Soc Nephrol 9(11): 2157-69 (1998)
1997  
38
1978  
39
Diabetic nephropathy--a review.
[364042] J Postgrad Med 24(3): 138-46 (1978)
2001  
40
Diabetic nephropathy: prevention and treatment.
[11703631] Kidney Int 60(5): 2041-55 (2001)
1999  
41
Molecular mechanisms of diabetic renal hypertrophy.
[10432377] Kidney Int 56(2): 393-405 (1999)
2008  
42
Rationale and strategies for early detection and management of diabetic kidney disease.
[19046557] Mayo Clin Proc 83(12): 1373-81 (2008)
1998  
43
Molecular biology of diabetic glomerulosclerosis.
[9870421] Nephrol Dial Transplant 13 Suppl 8(-): 20-5 (1998)
2004  
44
Recent advances in diabetic nephropathy.
[15537844] Postgrad Med J 80(949): 624-33 (2004)
1986  
45
The pathogenesis and prevention of diabetic glomerulopathy.
[3765603] West J Med 145(2): 235-7 (1986)
1994  
46
Structural-functional correlations of diabetic nephropathy.
[8164451] Kidney Int 45(2): 612-22 (1994)
1991  
47
Mechanisms of diabetic hyperfiltration.
[1745032] Kidney Int 40(4): 792-807 (1991)
2008  
48
Diabetic nephropathy: mechanisms of renal disease progression.
[18156300] Exp Biol Med (Maywood) 233(1): 4-11 (2008)
2009  
49
Epithelial-mesenchymal transition and podocyte loss in diabetic kidney disease.
[19781451] Am J Kidney Dis 54(4): 590-3 (2009)
2010  
50
C-peptide as a therapeutic tool in diabetic nephropathy.
[20357430] Am J Nephrol 31(5): 389-97 (2010)
2005  
51
Diabetic nephropathy: the proteinuria hypothesis.
[15746541] Am J Nephrol 25(2): 77-94 (2005)
2010  
52
Proteomic discovery of diabetic nephropathy biomarkers.
[21044770] Adv Chronic Kidney Dis 17(6): 480-6 (2010)
2008  
53
Renal complications of childhood type 1 diabetes.
[18349043] BMJ 336(7646): 677-8 (2008)
2011  
54
Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus.
[21531886] Mayo Clin Proc 86(5): 444-56 (2011)
2002  
55
Molecular mechanisms of diabetic mesangial cell hypertrophy: a proliferation of novel factors.
[12239252] J Am Soc Nephrol 13(10): 2611-3 (2002)
2010  
56
Proteinuria in diabetes: bystander or pathway to cardiorenal disease?
[21051738] J Am Soc Nephrol 21(12): 2020-7 (2010)
2008  
57
Stacking the deck for drug discovery in diabetic nephropathy: in search of an animal model.
[18684892] J Am Soc Nephrol 19(9): 1623-4 (2008)
2005  
58
Type 2 diabetic nephropathy: never too early to treat?
[15703269] J Am Soc Nephrol 16(3): 574-5 (2005)
2005  
59
Pathogenetic mechanisms of diabetic nephropathy.
[15938030] J Am Soc Nephrol 16 Suppl 1(-): S30-3 (2005)
2008  
60
Stressed-out podocytes in diabetes?
[18842987] J Am Soc Nephrol 19(11): 2035-7 (2008)
2009  
61
Aldosterone blockade in diabetic nephropathy: relative risks and potential promise.
[19875814] J Am Soc Nephrol 20(12): 2487-9 (2009)
2009  
62
Mouse models of diabetic nephropathy.
[19729434] J Am Soc Nephrol 20(12): 2503-12 (2009)
2003  
63
The mechanisms underlying altered vascular resistance of glomerular afferent and efferent arterioles in diabetic nephropathy.
[13679465] Nephrol Dial Transplant 18(10): 1966-9 (2003)
2007  
64
A breakthrough in diabetic nephropathy: the role of endothelial dysfunction.
[17595179] Nephrol Dial Transplant 22(10): 2775-7 (2007)
2009  
65
Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy.
[18972226] Endocrine 35(1): 1-10 (2009)
2010  
66
Diabetic nephropathy -- a multifaceted target of new therapies.
[21122472] Discov Med 10(54): 406-15 (2010)
2004  
67
New form of urinary albumin in early diabetes.
[15563484] Clin Chem 50(12): 2238-9 (2004)
2009  
68
2010  
69
TNF superfamily: a growing saga of kidney injury modulators.
[20953353] Mediators Inflamm 2010(-): - (2010)
2007  
70
Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease.
[17545302] Am J Physiol Renal Physiol 292(6): F1665-72 (2007)
2006  
71
2010  
72
Insights to the genetics of diabetic nephropathy through a genome-wide association study of the GoKinD collection.
[20347642] Semin Nephrol 30(2): 126-40 (2010)
2007  
73
Regulation of transforming growth factor beta in diabetic nephropathy: implications for treatment.
[17418684] Semin Nephrol 27(2): 153-60 (2007)
2007  
74
Histopathology of diabetic nephropathy.
[17418688] Semin Nephrol 27(2): 195-207 (2007)
2010  
75
The renal vascular response to diabetes.
[19770755] Curr Opin Nephrol Hypertens 19(1): 85-90 (2010)
2007  
76
The role of the renal kallikrein-kinin system in diabetic nephropathy.
[17143067] Curr Opin Nephrol Hypertens 16(1): 22-6 (2007)
2009  
77
Early nephropathy in type 1 diabetes: the importance of early renal function decline.
[19300247] Curr Opin Nephrol Hypertens 18(3): 233-40 (2009)
2009  
78
Role of altered insulin signaling pathways in the pathogenesis of podocyte malfunction and microalbuminuria.
[19724224] Curr Opin Nephrol Hypertens 18(6): 539-45 (2009)
2010  
79
Induction of diabetes in aged C57B6 mice results in severe nephropathy: an association with oxidative stress, endoplasmic reticulum stress, and inflammation.
[20363923] Am J Pathol 176(5): 2163-76 (2010)
2010  
80
TRB3 is stimulated in diabetic kidneys, regulated by the ER stress marker CHOP, and is a suppressor of podocyte MCP-1.
[20660016] Am J Physiol Renal Physiol 299(5): F965-72 (2010)
2010  
81
Identification of novel genetic markers and improved treatment options for diabetic kidney disease.
[20945986] Biomark Med 4(5): 739-41 (2010)
2012  
82
Decreased renal alpha-Klotho expression in early diabetic nephropathy in humans and mice and its possible role in urinary calcium excretion.
[22217880] Kidney Int 81(6): 539-47 (2012)
2004  
83
Diabetic nephropathy--a review of the natural history, burden, risk factors and treatment.
[15586648] J Natl Med Assoc 96(11): 1445-54 (2004)
2010  
84
The value of kidney biopsy in diabetes mellitus.
[20191114] Rom J Morphol Embryol 51(1): 13-9 (2010)
2009  
85
Genetics of diabetic nephropathy: are there clues to the understanding of common kidney diseases?
[19546580] Nephron Clin Pract 112(4): c213-21 (2009)
2011  
86
Telmisartan in incipient and overt diabetic renal disease.
[21374585] J Nephrol 24(3): 263-73 (2011)
2008  
87
Defining human diabetic nephropathy on the molecular level: integration of transcriptomic profiles with biological knowledge.
[18704688] Rev Endocr Metab Disord 9(4): 267-74 (2008)
2011  
88
Role of T cells in type 2 diabetic nephropathy.
[22028700] Exp Diabetes Res 2011(-): 514738 (2011)
2012  
89
Autophagy as a therapeutic target in diabetic nephropathy.
[22028701] Exp Diabetes Res 2012(-): 628978 (2012)
2008  
90
C-Peptide effects on renal physiology and diabetes.
[18509500] Exp Diabetes Res 2008(-): 281536 (2008)
2009  
91
C-Peptide: the missing link in diabetic nephropathy?
[20039009] Rev Diabet Stud 6(3): 203-10 (2009)
2008  
92
What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?
[18347777] Diabetologia 51(5): 714-25 (2008)
2003  
93
Remission and regression of diabetic nephropathy.
[12924617] Hypertens Res 26(7): 515-9 (2003)
2007  
94
Advantage of a low glycemic index and low phosphate diet on diabetic nephropathy and aging-related diseases.
[17878688] J Med Invest 54(3-4): 359-65 (2007)
2007  
95
Novel roles of the IGF-IGFBP axis in etiopathophysiology of diabetic nephropathy.
[17011663] Diabetes Res Clin Pract 76(2): 177-86 (2007)
2010  
96
Renin angiotensin aldosterone system (RAAS) inhibitors in the prevention of early renal disease in diabetes.
[20948868] F1000 Med Rep 2(-): - (2010)
2011  
97
Recent insights into diabetic renal injury from the db/db mouse model of type 2 diabetic nephropathy.
[21147843] Am J Physiol Renal Physiol 300(2): F301-10 (2011)
2011  
98
Genetic associations in diabetic nephropathy: a meta-analysis.
[21127830] Diabetologia 54(3): 544-53 (2011)
2010  
99
Effective antihypertensive strategies for high-risk patients with diabetic nephropathy.
[21030879] J Investig Med 58(8): 950-6 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Diabetes mellitus (Involvement kidney).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Diabetes mellitus (Involvement kidney).php on line 92